CABA - Cabaletta Bio, Inc.
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
8.18
-0.03 (-0.37%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
| Previous Close | 8.21 |
| Open | 9.17 |
| Bid | 6.70 x 1800 |
| Ask | 8.29 x 800 |
| Day's Range | 8.16 - 9.54 |
| 52 Week Range | 8.09 - 18.28 |
| Volume | 133,124 |
| Avg. Volume | 131,078 |
| Market Cap | 177M |
| Beta (3Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -16.61 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 22.00 |
- GlobeNewswire
Cabaletta Bio to Present at the Evercore ISI 2nd Annual HealthCONx Conference
PHILADELPHIA, Nov. 26, 2019 -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell.
- GlobeNewswire
Cabaletta Bio Announces Pricing of Initial Public Offering
PHILADELPHIA, Oct. 25, 2019 -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical stage biotechnology company focused on the discovery and development of engineered T cell.